Snag This Bargain Even Cheaper Than CEO Fambrough Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 10, Dicerna Pharmaceuticals Inc's CEO, Douglas Fambrough, invested $110,480.00 into 5,000 shares of DRNA, for a cost per share of $22.10..